Equipped with 12 continuous diffusion cells! A transdermal permeation testing device applicable to various transdermal absorption formulations.
The "Transview C12" is a transdermal permeation testing device that allows user-friendly operation via a touch panel. It features simultaneous automatic sampling and receptor replenishment from 12 diffusion cells. The unique heating system enables easy installation and setup of the diffusion cells. It is compatible with various formulations such as patches, ointments, creams, and lotions. 【Features】 ■ Equipped with 12 diffusion cells ■ Applicable to various transdermal absorption formulations ■ Easy installation and setup of diffusion cells with a unique heating system ■ User-friendly operation via a touch panel ■ Compatible with various formulations such as patches, ointments, creams, and lotions *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
【Specifications】 ■ Receptor Supply/Computer Control Unit (TVC12-RC) ■ Fraction Collector (TVC12-FC) ■ Heat Block Constant Temperature Bath (TVC12-IV) ■ Receptor Constant Temperature Bath (TVC12-RH) ■ Concentration Correction Program TransSoft ■ Various Diffusion Cells (13, 15, 17mm opening, 5.7ml receptor volume) ・Horizontal Type S Cell (TVC12-CLS) suitable for patches and ointments ・Horizontal Type L Cell (TVC12-CLL) suitable for lotions and solutions ・Vertical Cell (TVC12-CLV) ・Diffusion Cell for Iontophoresis (TVC12-CLI) *For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
【Purpose】 ■Transdermal absorption diffusion test *For more details, please refer to the PDF document or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Our company is engaged in the development of skin-related products as a specialized development company based on fundamental research of TTS (transdermal therapeutic system), focusing on transdermal pharmaceuticals, cosmetics, adhesive materials, and research equipment. In addition to the formulation of TTS preparations for polymer drugs such as proteins and polysaccharides using our unique technology, we are also advancing into the field of transdermal vaccines. We will continue to pursue further technological development and create new value.